Legal & General Group PLC Karuna Therapeutics, Inc. Transaction History

Legal & General Group PLC

$470 Billion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 15, 2024	SELL	$161.01 - $317.85 $295,131 - $582,619	-1,833 Reduced 5.29%	32,839 $10.4 Million
Q3 2023 Nov 14, 2023	BUY	$164.66 - $218.08 $408,027 - $540,402	2,478 Added 7.7%	34,672 $5.86 Million
Q2 2023 Aug 14, 2023	BUY	$176.32 - $240.22 $203,473 - $277,213	1,154 Added 3.72%	32,194 $6.98 Million
Q1 2023 May 15, 2023	BUY	$161.33 - $204.36 $520,127 - $658,856	3,224 Added 11.59%	31,040 $5.64 Million
Q4 2022 Feb 14, 2023	BUY	$191.53 - $236.82 $531,495 - $657,175	2,775 Added 11.08%	27,816 $5.47 Million
Q3 2022 Nov 14, 2022	BUY	$123.79 - $277.42 $292,020 - $654,433	2,359 Added 10.4%	25,041 $5.63 Million
Q2 2022 Aug 22, 2022	BUY	$93.97 - $143.33 $174,220 - $265,733	1,854 Added 8.9%	22,682 $2.87 Million
Q1 2022 May 16, 2022	BUY	$98.9 - $132.37 $236,173 - $316,099	2,388 Added 12.95%	20,828 $2.64 Million
Q4 2021 Feb 14, 2022	BUY	$110.64 - $159.4 $44,919 - $64,716	406 Added 2.25%	18,440 $2.42 Million
Q3 2021 Nov 15, 2021	BUY	$101.2 - $125.87 $404,091 - $502,598	3,993 Added 28.44%	18,034 $2.21 Million
Q2 2021 Aug 12, 2021	BUY	$107.45 - $135.95 $497,063 - $628,904	4,626 Added 49.13%	14,041 $1.6 Million
Q1 2021 May 17, 2021	SELL	$95.46 - $133.08 $2,386 - $3,327	-25 Reduced 0.26%	9,415 $1.13 Million
Q4 2020 Feb 12, 2021	SELL	$75.23 - $109.23 $4,363 - $6,335	-58 Reduced 0.61%	9,440 $959,000
Q3 2020 Nov 13, 2020	BUY	$71.31 - $109.74 $378,727 - $582,829	5,311 Added 126.84%	9,498 $734,000
Q2 2020 Aug 14, 2020	BUY	$62.14 - $117.21 $158,891 - $299,705	2,557 Added 156.87%	4,187 $466,000
Q1 2020 May 14, 2020	BUY	$60.41 - $115.92 $45,730 - $87,751	757 Added 86.71%	1,630 $117,000
Q4 2019 Feb 13, 2020	BUY	$11.44 - $123.99 $1,670 - $18,102	146 Added 20.08%	873 $66,000
Q3 2019 Nov 13, 2019	BUY	$16.05 - $27.35 $11,668 - $19,883	727 New	727 $12,000

Others Institutions Holding KRTX

# of Institutions

Shares Held

332K

Call Options Held

Put Options Held

View Full List

About Karuna Therapeutics, Inc.

Ticker KRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,965,000
Description
Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate is KarXT, an oral modulator of muscarinic receptors that is in Phase III clinical trial for the treatment of acute psychosis in patients wi...

More about KRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.

Account